Zymeworks Inc.
Pharmaceutical Preparations · 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
官方登记数据
0位关注者
2003成立于
关于 Zymeworks Inc.
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Source: Wikipedia
行业Pharmaceutical Preparations
总部108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
成立2003
法律形式C Corporation
状态营业中
专利417 项专利
CYSTEINE ENGINEERED ANTIBODY CONSTRUCTS, CONJUGATES AND METHODS OF USEUS20260042847A1 · 2026
MODIFIED ANTIGEN BINDING POLYPEPTIDE CONSTRUCTS AND USES THEREOFCA3177027C · 2025
关键数据
法律信息
| 法定名称 | Zymeworks Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1937653在 SEC EDGAR 上查看 ↗ |
| EIN | 88-3099146 |
| 行业代码(SIC) | 2834 |
| 注册地址 | 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面